Pervasive developmental disorder not otherwise specified

Editor-In-Chief: Prab R Tumpati, MD
Obesity, Sleep & Internal medicine
Founder, WikiMD Wellnesspedia &
W8MD's weight loss doctor NYC
Philadelphia GLP-1 weight loss and GLP-1 clinic NYC
| Pervasive developmental disorder not otherwise specified | |
|---|---|
| |
| Synonyms | N/A |
| Pronounce | N/A |
| Specialty | N/A |
| Symptoms | Impaired social interaction, communication difficulties, repetitive behaviors |
| Complications | N/A |
| Onset | Early childhood |
| Duration | Lifelong |
| Types | |
| Causes | Unknown, possibly genetic and environmental factors |
| Risks | Family history of autism spectrum disorder |
| Diagnosis | Based on behavioral assessment |
| Differential diagnosis | Autism, Asperger syndrome, Childhood disintegrative disorder |
| Prevention | N/A |
| Treatment | Behavioral therapy, speech therapy, occupational therapy |
| Medication | Antipsychotics, antidepressants |
| Prognosis | Varies, some individuals may improve with therapy |
| Frequency | Unknown, part of the autism spectrum disorder |
| Deaths | N/A |
Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS), including atypical autism, is a classification of autism spectrum disorders (ASDs) in the DSM-5 and was previously a part of the broader category of Pervasive Developmental Disorders (PDD) in the DSM-IV.
Introduction[edit]
PDD-NOS is used to describe individuals with significant impairments in social and communication skills, as well as stereotypical behaviors, but who do not fully meet the criteria for other specific disorders within the autism spectrum.
Criteria and Diagnosis[edit]
According to the DSM-IV, PDD-NOS is diagnosed based on severe impairment in the development of reciprocal social interaction, verbal and nonverbal communication skills, or when stereotyped behavior, interests, and activities are present. This includes cases where symptoms of autism are present but do not fully meet the complete criteria, such as:
- Late age of onset
- Atypical symptomatology
- Subthreshold symptomatology
Characteristics[edit]
PDD-NOS encompasses a range of symptoms and behaviors, including:
- Difficulties in social interaction
- Challenges in verbal and nonverbal communication
- Repetitive behaviors or narrow, obsessive interests
- Variability in cognitive and language abilities
Changes in DSM-5[edit]
In the DSM-5, PDD-NOS, along with other subtypes of autism, were subsumed under the single diagnosis of Autism Spectrum Disorder (ASD). This change reflects a more nuanced understanding of autism as a spectrum of disorders with varying symptoms and severities.
Management and Treatment[edit]
Treatment for PDD-NOS is individualized and may include:
- Behavioral interventions
- Speech and language therapy
- Occupational therapy
- Educational support
- Medication for associated symptoms such as anxiety or ADHD
Historical Perspective[edit]
PDD-NOS, including atypical autism, emerged as a diagnostic category to capture those individuals who did not meet the criteria for classical autism or other specific disorders, highlighting the diversity within the spectrum of developmental disorders.
References[edit]
|
This article is a stub You can help WikiMD by registering and expanding it with useful details, internal links, formatting, and categories. Editing is available only to registered and verified users. WikiMD is a comprehensive, free health and wellness encyclopedia. |
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
